MiMedx Group Inc

NASDAQ:MDXGUnited States

MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.

Contact Information

Headquarters

1775 W Oak Commons Court, NeMARIETTA, GA, United States 30062

Phone

770-651-9100

Fax

678-384-6720

Executives

Independent Chairman of the Board

M. Kathleen Behrens Wilsey

Chief Executive Officer, Director

Joseph Capper

Chief Financial Officer

Douglas Rice

Executive Vice President, Chief Operating Officer

Ricci Whitlow

Chief Administrative Officer, General Counsel

William Hulse